Pacemakers Global Market Report 2023 – By Type (MRI Compatible Pacemaker Conventional Pacemaker), By Technology (Single-Chamber Pacemaker Dual-Chamber Pacemaker Biventricular or CRT Pacemaker), By Implantability (Implantable Pacemaker External Pacemaker), By Application (Congestive Heart Failure Arrhythmias Bradycardia Tachycardia), By End-User (Hospitals Cardiac Care Centres Ambulatory Surgical Centres Other End Users) – Market Size, Trends, And Global Forecast 2023-2032

3D printed medical devices are artificial devices that replace a missing body part or biological structure and are manufactured by laying successive layers of material using inputs from a digital 3D model. The main types of 3D printed medical devices are implants, surgical instruments, prosthetics, tissue engineering devices, and others. The 3D-printed implants are medical implants that are made using 3D printing technology to create complex geometries. These are made up of raw materials such as plastics, biomaterial inks, and metals and alloys. The technologies involved in 3D printed medical devices are fused deposition modeling, digital light processing, stereolithography, and selective laser melting. These provide applications in orthopedic, spinal, dental, hearing aids, and others that are used by end-users such as hospitals, diagnostics centres, academic institutions, and others. The global 3D printed medical devices market is segmented – 1) By Type: Implants, Surgical instruments, Prosthetics, Tissue engineering devices, Other Types 2) By Application: Orthopedic, Spinal, Dental, Hearing Aids, Other Applications 3) By Technology: Fused Deposition Modelling, Digital Light Processing, Stereolithography, Selective Laser melting 4) By Raw Material: Plastics, Biomaterial inks, Metals and Alloys 5) By End User: Hospitals, Diagnostics Centres, Academic Institutions, Other End Users The global 3d printed medical devices market size grew from $2.87 billion in 2022 to $3.57 billion in 2023 at a compound annual growth rate (CAGR) of 24.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global 3d printed medical devices is expected to grow to $9.09 billion in 2027 at a CAGR of 26.3%. The increasing prevalence of osteoarthritis and similar musculoskeletal conditions is one of the major factors driving the growth of the 3D printed medical devices market. Osteoarthritis is a disorder that damages the joint cartilage and surrounding tissues causing pain, stiffness, and loss of joint function to the person affected by it. The 3D printing medical devices enable the creation of a replica of a patient's joint, which can provide surgeons with a crucial piece of information that might not be visible on a 2-dimensional scan. The chance of developing osteoarthritis increases with age. For instance, according to the US National Library of Medicine report, by 2040, it is estimated that approximately 78 million (26%) US adults aged 18 years and above will be projected to have doctor-diagnosed arthritis. Thereby driving the adoption of 3D printed medical devices, positively impacting the 3d printed medical devices market growth. Major players in the 3D printed medical devices market are 3D Systems Corporation, EnvisionTEC, Stratasys Ltd., Arcam AB, Cyfuse Biomedical, Materialise NV, Organovo Holdings, EOS GmbH, FabRx Ltd., and Concept Laser. Biocompatibility issues related to 3D printed medical devices restrict the growth of the 3D printed medical devices market. Biocompatibility implies the properties that make a material or a device compatible with the human body. If the material used for the preparation of a 3D printed implant device is not compatible with the patients' biomechanics, then patients may suffer side effects such as abnormal growth of bone and bleeding. Among the most common metal used in the manufacturing of 3D printed medical devices is Titanium. Though Titanium offers reliability and accuracy in creating medical-grade products, some human bodies tend to reject titanium as its chemical composition can inhibit the bone and tissue from interacting with the implant. Apart from these other reasons which may contribute to the failure of metallic implants that are either caused by the material properties of the metal (e.g., high stiffness, high corrosion rate, and toxicity) itself or by the exposure of the bone to infected metal implants i.e., infection. The increasing use of 3D printing technology in the spine industry is one of the latest trends in the 3D printed medical devices market. The spine industry is adopting 3D printing to produce new innovative products that can promote bone ingrowth and improve implant fixation to spine bone, reducing the number of manufacturing steps, thereby making the 3D printing process more cost-effective in several cases. For instance, Medtronic launched its titanium 3D printed platform – TiONIC Technology. TiONIC Technology is a 3D printed technique that uses laser methods to create implants with enhanced surface textures. Artic-L is the first implant created by the company using TiONIC Technology. The implant is made up of titanium and is designed to be used by surgeons in spine surgery. In addition to that, K2M’s Lamellar, introduced its 3D Titanium Technology to create a 3D spinal implant. The 3D printing medical device using titanium technology uses an advanced 3D printing method to create structures that were once considered impractical with traditional manufacturing techniques. The implants use titanium powder and are associated with bone growth activity. Food and Drug Administration (FDA) has a Centre for Device and Radiological Health (CDRH) to regulate the firm which manufacture, repackage, relabel and/or import 3D printing medical devices in the US. FDA provides manufacturers with a draft with guidance that includes recommendations for device design, manufacturing, and testing considerations during the development of 3D printing medical devices. Section F of the 'Technical Considerations for Additive Manufactured Medical Device' draft, requires the manufacturers to evaluate the biocompatibility of the final finished device as described in the guidance "Use of International Standard ISO-10993". The guidelines also require the manufacturer of the 3D printing devices to mention the additional information in the label if any toxic chemical additives such as certain additives, catalysts, binding and curing agents, uncured monomers, and plasticizers are used in making 3D printing medical devices. In July 2020, Medtronic, an American Irish-domiciled medical device company acquired Medicrea International for an undisclosed amount. The acquisition of Medicrea expands Medtronic’s already deep portfolio as this adds to their spinal solution profile as the advent of new digital technology will offer the ability to custom spinal implants. Medicrea International is a spinal surgery company with 30+ FDA-approved spinal implant technologies that have been utilized in over 150,000 spinal surgeries to date. North America was the largest region in the 3D printed medical devices market in 2022. Western Europe was the second largest region in the 3D printed medical devices market. The regions covered in the 3D printed medical devices market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the 3D printed medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The 3D printed medical devices market consists of sales of 3D printed prosthetics and implants. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The 3D printed medical devices market research report is one of a series of new reports from The Business Research Company that provides 3D printed medical devices market statistics, including 3D printed medical devices industry global market size, regional shares, competitors with a 3D printed medical devices market share, detailed 3D printed medical devices market segments, market trends and opportunities, and any further data you may need to thrive in the 3D printed medical devices industry. This 3D printed medical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Wearable medical devices are autonomous medical devices that can be worn by a person and perform functions such as medical monitoring and support. The main types of wearable medical devices are diagnostic devices and therapeutic devices. The diagnostic devices are used for diagnosing patient outcomes. The various product types include watches, wristbands, clothing, earwear, and other devices. These are used in sports and fitness, remote patient monitoring, home healthcare, and ear wear. The various distribution channels are pharmacies, online channels, and hypermarkets. The global wearable medical devices market is segmented - 1) By Device Type: Diagnostic Devices, Therapeutic Devices 2) By Product Type: Watch, Wristband, Clothing, Ear Wear, Other Devices 3) By Distribution Channel: Pharmacies, Online Channel, HyperMarkets 4) By Application: Sports And Fitness, Remote Patient Monitoring, Home Healthcare, Ear Wear The global wearable medical devices market size will grow from $22.44 billion in 2022 to $27.37 billion in 2023 at a compound annual growth rate (CAGR) of 21.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global wearable medical devices market size is expected to grow to $60.48 billion in 2027 at a CAGR of 21.9%. The wearable medical devices market covered in this report is segmented by device type into diagnostic devices, therapeutic devices. It is also segmented by product type into watch, wristband, clothing, ear wear, other devices, by distribution channel into pharmacies, online channel, hypermarkets and by application into sports and fitness, remote patient monitoring, home healthcare, ear wear. Major players in the wearable medical devices market are Philips, Polar Electro, Omron Corporation, Fitbit Inc., Garmin Ltd., LifeWatch AG (BioTelemetry Inc.), Xiaomi Inc., VitalConnect, Jawbone Inc., General Electric Co., and Medtronic PLC. The rise in mortality rate due to non-communicable diseases with an increasing prevalence of chronic diseases and lifestyle-associated diseases like hypertension and diabetes contributed to the growth of wearable medical devices. The Healthcare industry is coming up with newer technologies to overcome this with necessary measures like continuous and remote patient monitoring facilities through wearables which can be worn over the body all-day long for continuous monitoring of the required parameters like vital signs, glucose levels, and more. According to the world health organization (WHO), 2020, Non-communicable diseases (NCDs) will estimate 80% of the global disease burden. Seven out of every ten deaths in developing countries are caused by NCDs, and around half of these deaths are in people younger than 70 years. Moreover, the global NCD burden will rise by 17% in the next decade, and in Africa., it will grow by 27%. According to the International Diabetes Federation, an international organization working for spreading awareness regarding diabetes, in 2021, 537 million adults were living with diabetes. This number is expected to increase to 643 million by 2030 and 783 million by 2045. The rise in the number of chronic diseases coupled with growing awareness among the people is pushing them towards continuous monitoring which boosted the wearable medical devices market growth. Wearable device manufacturers collect and store data to sell them to the customer itself by charging a certain amount on monthly basis or periodically as per the requirement or to third parties at places where this information is not considered as Protected Health Information. There is a higher exposure of sensitive data as the amount of data handled by Medical Internet of Things devices is growing exponentially. The major data privacy concerns arise during the transmission of data to a cloud and during its storage. In July 2022, according to a survey released by American Medical Association (AMA), a US-based healthcare association, 92% of the respondents were in favour of maintaining their privacy and agreed that the medical data should not be sold to companies. There are risks of the access and security of the personal information collected by the third-party healthcare service providers which are expected to hamper the growth of the wearable medical devices market during the forecast period. Integrating artificial intelligence into wearable medical devices is gaining traction. The data collected by wearable medical devices lack value without the integration of artificial intelligence (AI) that better utilizes the data collected. AI doctor which is a standalone network with a deep learning algorithm performs well than trained medical practitioners in conditions like skin lesions, electrocardiograms, medical imaging, and pathology. In 2020, Apple acquired Xnor.ai that develops technology like artificial intelligence to gain access to low-power AI tools for image recognition in wearables and others. A survey published in 2022 showed that 88% of the respondents were aware about AI. 46% of the respondents believed that the benefits of AI in healthcare outweighed the risk while only 2% agreed the opposite. The wearable device app developers are increasingly focused on integrating AI into the apps to analyze the remotely collected data for better interpreting the ailment by an AI doctor. North America was the largest region in the wearable medical devices market in 2022. Asia-Pacific was the second-largest region in the global wearable medical devices market analysis. The regions covered in the global wearable medical devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the wearable medical devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and USA. The wearable medical devices market consists of sales of wearble ECG monitors, wearable fitness tracker, biosensors and others that are wearable and are used for monitoring medical conditions. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The wearable medical devices market research report is one of a series of new reports from The Business Research Company that provides wearable medical devices market statistics, including wearable medical devices industry global market size, regional shares, competitors with a wearable medical devices market share, detailed wearable medical devices market segments, market trends and opportunities, and any further data you may need to thrive in the wearable medical devices industry. This wearable medical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Cardiac rhythm management (CRM) devices and equipment are used to manage the heart rate or rhythm by generating electrical impulses or shocks in order to get the heart back to its normal functions. CRM devices are used to treat and manage arrhythmia-related diseases such as cardiac arrests, heart failure, or cardiac arrhythmias. The main products of cardiac rhythm management devices and equipment are pacemakers, defibrillators, and cardiac resynchronization therapy (CRT). A pacemaker is a small device that's placed in the chest to control the heartbeat. It's used to prevent the heart from beating too slowly. The defibrillators are implantable cardioverter defibrillators and external defibrillators. Cardiac resynchronization therapy (CRT) includes CRT-defibrillators (CRT-D), CRT-pacemakers (CRT-P). There are implantable pacemakers and external pacemakers. The applications involved are bradycardia, tachycardia, heart failure, and others that are used by various end-users such as hospitals, ambulatory surgical centres, and physician’s clinics. The global cardiac rhythm management (CRM) devices and equipment market is segmented - 1) By Product: Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT) 2) By End User: Hospitals, Ambulatory surgical centers, Physicians Clinics 3) By Application: Bradycardia, Tachycardia, Heart Failure, Other Applications 4) By Pacemakers: Implantable Pacemakers, External Pacemakers 5) By Defibrillators: Implantable Cardioverter Defibrillators, External Defibrillator 6) By Cardiac Resynchronization Therapy (CRT): CRT-Defibrillators (CRT-D), CRT-Pacemakers (CRT-P) The global cardiac rhythm management (CRM) devices and equipment market size will grow from $15.13 billion in 2022 to $16.19 billion in 2023 at a compound annual growth rate (CAGR) of 7.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the cardiac rhythm management (CRM) devices and equipment is expected to grow to $20.05 billion in 2027 at a CAGR of 5.5%. The rising incidences of cardiovascular diseases such as cardiac arrhythmia, ischemic heart disease, and hypertension is driving the CRM devices market. Sedentary lifestyles and medical conditions such as high cholesterol, high blood pressure, obesity, and diabetes are major causes of cardiovascular diseases. According to the World Health Organization, cardiovascular diseases account for about 31% of all global deaths. Most of these deaths occur due to heart attacks and strokes. As more people suffer from cardiovascular diseases, the demand for cardiac rhythm management and devices is expected to increase. Major players in the cardiac rhythm management (CRM) devices and equipment market are Abbott, Medtronic, Biotronik, Cardiac Science Corporation, Schiller AG, Hill-Rom Holdings Inc., GE Healthcare, Integer, Biotelemetry, and Neovasc. The risks associated with cardiac rhythm management devices and equipment market is acting as a restraint on the market. CRM devices may pose potential risks such as post-implant infections and contraindications in patients undergoing any type of radiation therapy or diagnosis. Implantable CRM devices contain complementary metal-oxide-semiconductor (CMOS) which may get damaged due to therapeutic doses of radiation. Also, as the implants are highly sensitive devices, any dysfunction may have life-threatening consequences for the patients. The considerable number of risks involved in using CRM devices are affecting the cardiac rhythm management (CRM) devices and equipment market growth. Technologies such as subcutaneous implantable cardioverter-defibrillator (S-ICD) and leadless cardiac pacemakers (LCP) are being developed to overcome complications with transvenous lead and other CRM devices. The novel modular cardiac rhythm management (mCRM) system allows for the coordination of leadless pacing and defibrillator therapy delivery by providing wireless intra-body communication between devices. This communication is possible by a combination of anti-tachycardia pacing-enabled LCP and S ICD. For instance, Medtronic developed the leadless pacemaker Micra which can be placed in the heart through veins and is self-contained within the heart. Manufacturers of cardiac rhythm management devices and equipment are governed by various regulatory bodies such as the FDA in the USA. The United States Food and Drug Administration recalls any product with safety issues or defects that can endanger the consumer. The FDA recalled the Platinium implantable cardiac defibrillator and resynchronization therapy defibrillator due to issues with hardware configuration and functioning. The company had to discard all non-implanted Platinium devices and follow up with all patients implanted with these devices. North America was the largest region in the global cardiac rhythm management (CRM) devices and equipment market in 2022. Western Europe was the second-largest region in the cardiac rhythm management (CRM) devices and equipment market share. The regions covered in the global cardiac rhythm management (CRM) devices and equipment market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the cardiac rhythm management (CRM) devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The cardiac rhythm management (CRM) devices and equipment market consist of sales of Pacemakers, (implantable pacemakers, external pacemakers), defibrillators (implantable cardioverter defibrillators, external defibrillators), and cardiac resynchronization therapy (CRT-defibrillators, CRT-pacemakers) that are used for rhythm management. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The cardiac rhythm management (CRM) devices and equipment market research report is one of a series of new reports from The Business Research Company that provides cardiac rhythm management (CRM) devices and equipment market statistics, including cardiac rhythm management (CRM) devices and equipment industry global market size, regional shares, competitors with a cardiac rhythm management (CRM) devices and equipment market share, detailed cardiac rhythm management (CRM) devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac rhythm management (CRM) devices and equipment industry. This cardiac rhythm management (CRM) devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Chemicals are used in antimicrobial coatings to prevent pathogen growth by disrupting cellular membranes. In other words, an antimicrobial coating is a chemical substance that is applied to a surface to prevent disease-causing microorganisms from growing. These coatings not only improve the surface's durability, appearance, corrosion resistance, and so on, but they also protect it against disease-causing bacteria. The main types of antimicrobial medical device coatings are metallic coatings and non-metallic coatings. Metallic coatings contain a metallic element or alloy and are applied on devices or equipment for protection against corrosion, sunlight, and oxidation. Metallic coatings consist of silver coatings, copper coatings, and other metallic coatings. Non-metallic coatings can be added to metallic coatings to produce effective wear-resistant coatings. The different types of devices include catheters, implantable devices, surgical instruments, and others. It is implemented in areas such as orthopedics, general surgery, dentistry, cardiovascular, gynecology, and others and is used in hospitals, diagnostic centers, and ambulatory surgical centers. The global antimicrobial medical device coatings market is segmented - 1) By Type of Material: Metallic Coatings, Non Metallic Coatings 2) By Device Type: Catheters, Implantable Devices, Surgical Instruments, Other Device Types 3) By Application: Orthopedics, General Surgery, Dentistry, Cardiovascular, Gynecology, Other Applications 4) By End User: Hospitals, Diagnostic Centers, Ambulatory Surgical Centers The global antimicrobial medical device coatings market size grew from $2.1 billion in 2022 to $2.43 billion in 2023 at a compound annual growth rate (CAGR) of 16.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The antimicrobial medical device coatings market size is expected to grow to $4 billion in 2027 at a CAGR of 13.2%. The rising cardiovascular diseases drive the growth of the antimicrobial medical device coatings market over the coming years. CVDs (cardiovascular diseases) are a category of heart and blood vessel problems. Cardiovascular diseases (CVDs) are the primary, source of death worldwide with low- and middle-income nations accounting for three-quarters of CVD deaths. Antimicrobial coated cardiovascular devices are used for the treatment of cardiovascular diseases and disorders. According to the World Health Organization (WHO) report in 2021, cardiovascular diseases claimed the lives of 17.9 million individuals worldwide in 2019, accounting for 32% of all deaths. Heart attacks and strokes were responsible for 85% of these deaths. Major players in the antimicrobial medical device coatings market are AST Products Inc., BioInteractions Ltd., Covalon Technologies Ltd., Royal DSM, Hydromer, BASF SE, Sciessent LLC, DuPont de Nemours Inc., Kraton Corporation, Sono-Tek Corporation, and Microban International. The growing technological advancements are shaping the antimicrobial medical device coatings market. Major companies operating in the antimicrobial medical device coating sector are focused on developing technological solutions for antimicrobial medical device coatings to prevent the spread of viruses. For instance, in November 2020, Zonitise Ltd., a UK-based biotech firm, introduced an antimicrobial surface treatment based on nanotechnology that has been shown to destroy hazardous viruses and bacteria for up to twelve months after one application, including TGEV COVID-19, the model virus for SARS COV 2. This coating not only disinfects surfaces but also protects them in an antimicrobial sealant that destroys and prevents the formation of any hazardous bacteria that come into touch with it for up to twelve months. In February 2021, Bain Capital, a US-based investment firm, and Cinven, a UK-based private equity firm acquired Lonza Specialty Ingredients (LSI), a division of Lonza AG for $4.7 billion. Through this acquisition, LSI provides a range of differentiated specialty chemical products, underpinned by strong R&D capabilities, regulatory and IP protections, and a highly qualified and dedicated workforce. Lonza Specialty Ingredients (LSI) is a US-based company that specializes in microbial control for personal care as well as mold and other potential pathogen prevention in homes, schools, workplaces, and the environment. North America was the largest region in the antimicrobial medical device coatings market in 2022. Europe was the second-largest market in the antimicrobial medical device coatings market. The regions covered in the antimicrobial medical device coatings market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the antimicrobial medical device coatings market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The antimicrobial medical device coatings market consists of sales of non-metallic antimicrobial medical device coating including polymeric and organic coatings. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The antimicrobial medical device coatings market research report is one of a series of new reports from The Business Research Company that provides antimicrobial medical device coatings market statistics, including antimicrobial medical device coatings industry global market size, regional shares, competitors with an antimicrobial medical device coatings market share, detailed antimicrobial medical device coatings market segments, market trends and opportunities, and any further data you may need to thrive in the antimicrobial medical device coatings industry. This antimicrobial medical device coatings market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical device cleaning are used for cleaning and sanitization of medical instruments, and other medical devices. Medical device cleaning is a vital part of any surgical process. It is a method of sterilizing medical devices and equipment to avoid infecting patients or causing illness. The common methods used for cleaning medical devices are ultrasonic cleaners, automatic washers, and manual washing. The main type of medical device cleaning processes includes disinfection, automatic cleaning, manual cleaning, and presoak/precleaning. Manual cleaning is the physical removal of all visible soil (gross debris) from an item to render it safe for handling and further processing for patient care. It is used for cleaning surgical instruments, endoscopes, ultrasound probes, dental instruments, and other instruments in hospitals & clinics, diagnostic centers, dental clinics, and others. The global medical device cleaning market is segmented - 1) By Process: Disinfection, Automatic Cleaning , Manual Cleaning, Presoak/Precleaning 2) By Application: Surgical Instruments, Endoscopes, Ultrasound Probes, Dental Instruments, Other Applications 3) By End Users: Hospitals and Clinics, Diagnostic Centers, Dental Clinics, Other End Users The global medical device cleaning market size grew from $2.5 billion in 2022 to $2.71 billion in 2023 at a compound annual growth rate (CAGR) of 8.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The market size of the global medical device cleaning is expected to grow to $3.74 billion in 2027 at a CAGR of 8.3%. The increasing number of surgical procedures with a surge in the prevalence of chronic diseases drives the growth of the medical device cleaning market. The increasing prevalence of various chronic conditions such as cancer, cardiovascular diseases, gynecology-related issues, and orthopedic cases has led to a significant increase in the number of medical device cleaning disinfectants and other products. For instance, according to the Global Cancer Observatory (GLOBOCAN), the global incidence of cancer cases in 2020 was estimated to be around 19.3 million cases. Moreover, as per the American Cancer Society estimates, the global cancer burden will increase to 27.5 million new cancer cases by 2040. The number of people affected with chronic diseases continues to grow across the globe increasing the number of surgical procedures. Hence, the increasing number of surgical procedures will boost the growth of the medical device cleaning market size during the forecast period. Major players in the medical device cleaning market are 3M, Getinge AB, STERIS plc, Cantel Medical Corporation, Ecolab Inc., Advanced Sterilization Products, Oro Clean Chemie AG, Ruhof Corporation, Biotrol, Metrex Research LLC., Sklar Surgical Instruments, Tristel Solutions Ltd., Hartmann Group, Medivators Inc., Case Medical Inc., and Fortive Corporation. Players in the medical devices cleaning market are increasingly focusing on UV sanitizer devices. The UV sanitizer is effective in treating bacteria present in medical devices and operating rooms. For instance, PurpleSun Inc. a US-based company developed Ultraviolet (UV) technology to reduce more than 96% of microorganisms in operating rooms (ORs) and on medical equipment, compared to 38% using manual cleaning methods that rely on chemicals to sanitize surfaces. In August 2021, MicroCare, LLC, a US-based manufacturer of critical cleaning, coating, and lubrication fluids and tools acquired Certol International. With the acquisitions, Certolis expected to be a perfect fit with Microcare’s approach of providing a full spectrum of critical cleaning options to its customers. MicroCare and Certol can provide customers with a larger product selection, faster delivery, and better customer service by combining its two organizations’ quality products, brands, and global distribution capabilities. Certol International is a US-based provider of healthcare and industrial products. North America was the largest region in the medical device cleaning market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device cleaning market share report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the medical device cleaning market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The medical device cleaning market consists of revenues earned by entities by providing washer-decontaminators, ultrasonic cleaners and washer-disinfectors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The medical device cleaning market research report is one of a series of new reports from The Business Research Company that provides medical device cleaning market statistics, including medical device cleaning industry global market size, regional shares, competitors with a medical device cleaning market share, detailed medical device cleaning market segments, market trends and opportunities, and any further data you may need to thrive in the medical device cleaning industry. This medical device cleaning market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical device outsourcing is a process in which a company outsources the manufacturing process of a medical device to another company. The main types of products in medical device outsourcing are finished goods, electronics, and raw materials. Products that have passed or completed the production process but have not yet been sold or dispersed to the ultimate consumer are referred to as finished goods. The various device types are class I devices, Class II devices, and class III devices that provide services such as quality assurance, regulatory affair services, product design development, product testing, and sterilization, product implementation, product upgrade, product maintenance, and contract manufacturing. It has various applications including drug delivery, dental, diabetes care, cardiology, endoscopy, IVD, ophthalmic, diagnostic imaging, orthopedics, and general and plastic surgery. The global medical device outsourcing market is segmented – 1) By Product: Finished Goods, Electronics, Raw Materials 2) By Device Type: Class I Devices, Class II Devices, Class III Devices 3) By Services: Quality Assurance, Regulatory Affair Services, Product Design Development, Product Testing And Sterilization, Product Implementation, Product Upgrade, Product Maintenance, Contract Manufacturing 4) By Application: Drug Delivery, Dental, Diabetes Care, Cardiology, Other Applications The global medical device outsourcing market size grew from $114.95 billion in 2022 to $129.4 billion in 2023 at a compound annual growth rate (CAGR) of 12.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global medical device outsourcing is expected to grow to $204.25 billion in 2027 at a CAGR of 12.1%. The prevalence of chronic diseases is expected to propel the growth of the medical device outsourcing market going forward. Chronic diseases are the conditions that last 1 year or more and require ongoing medical attention or limit activities of daily living or both. The rising chronic diseases increase the demand for new quality medical products in less launch time thereby driving the growth of the medical devices outsourcing market. For instance, according to the UN Chronicle, a digital magazine of the United Nations, the global burden of chronic diseases is expected to reach about 56% by 2030. Therefore, the prevalence of chronic diseases will drive the growth of the medical device outsourcing market. Major players in the medical device outsourcing market are Flex Ltd., Integer Holdings Corporation, Plexus Corp., Toxikon Inc., Eurofins Scientific SE, Pace Analytical Services Inc., WuXi AppTec Inc., North American Science Associates Inc., Charles River Laboratories International Inc., Creganna, IQVIA, Mitutoyo Corporation, Cardinal Health Inc., Onex Corporation, Te Connectivity Ltd., Nortech Systems Incorporated, Sanmina Corporation, and Sterigenics International LLC. Strategic partnerships and collaborations have emerged as a key trend gaining popularity in the medical device outsourcing market. Major companies operating in the market are focusing on partnerships and collaborations to lead the market. For instance, in December 2021, Labcorp, a US-based laboratory testing company acquired Toxikon Corporation for an undisclosed amount. This acquisition would extend Labcorp’s portfolio of full-service drug development and medical device solutions from discovery to market approval. Toxikon Corporation is a US-based contract manufacturing company that provides outsourcing services for medical devices. Furthermore, in February 2020, Integer Holdings, a US-based advanced medical device outsourcing company acquired Inomec for an undisclosed amount. This acquisition of Inomec will allow Integer to establish a research and development and sales center in Israel, in addition to optimizing its catheter design, clinical, and pilot manufacturing capabilities. Income is an Israel-based medical device outsourcing company. In December 2021, Integer Holdings, a US-based advanced medical device outsourcing company, acquired Oscor Inc. for $220 million. This acquisition of Oscor strengthens Integer’s ability to serve customers by expanding the product offering in steerable sheaths and cardiac and neurostimulation leads and adding low-cost manufacturing capacity to support growth. Oscor is a US-based company that operates in medical device outsourcing services. North America was the largest region in the medical device outsourcing market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device outsourcing market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the medical device outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The medical device outsourcing market includes revenues earned by entities by providing services such as design and development. Components and devices manufacturing, process validation and verification, Packaging, regulatory consultation, and full services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The medical device outsourcing market research report is one of a series of new reports from The Business Research Company that provides medical device outsourcing market statistics, including medical device outsourcing industry global market size, regional shares, competitors with a medical device outsourcing market share, detailed medical device outsourcing market segments, market trends and opportunities, and any further data you may need to thrive in the medical device outsourcing industry. This medical device outsourcing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Cathode materials refer to batteries that include a variety of products that cater to different user needs for high energy density and high load capacity. These materials are comprised of cobalt, nickel, and multi-metal oxide materials to which lithium is added. It is used to identify the capacity and power of a battery. The cathode materials market consists of the sale of cathode materials by entities (organizations, sole traders, and partnerships) that are used to identify the capacity and power of a battery. Cathode materials refer to batteries that include a variety of products that cater to different user needs for high energy density and high load capacity. These materials are comprised of cobalt, nickel, and multi-metal oxide materials to which lithium is added. The global cathode materials market is segmented - 1) By Material: Lithium Cobalt Oxide or Lithium Cobaltate, Lithium Manganese Oxide or Spinel or Lithium Manganate, Lithium Iron Phosphate or Lithium Nickel Manganese Cobalt (NMC), Lithium Nickel Cobalt Aluminum Oxide, Sulfur Cathodes, Sodium Cobalt Oxide, Other Materials 2) By Battery Type: Lead-Acid, Lithium-Ion, Other Battery Types 3) By Application: Portable Gadgets, Medical Devices (Cardiac Pacemakers, Implantable Cardiac Defibrillators (ICDs), and Others), Power Tools, Wireless Peripherals or Cordless Devices, Power Storage Systems, Other Applications The global cathode materials market size grew from $18.57 billion in 2022 to $20.43 billion in 2023 at a compound annual growth rate (CAGR) of 10.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The market size of the cathode materials is expected to grow to $27.91 billion in 2027 at a CAGR of 8.1%. The growing usage of batteries in electric vehicles is expected to propel the growth of the cathode materials market going forward. Electric vehicles refer to vehicles that are either partially or fully run on electricity. Cathode materials are used in Li-ion batteries in electric vehicles to generate electricity through chemical reactions. For instance, according to Power-Technology, a US-based journal which provides information on the global energy industry, there was an increase in the sale of electric vehicles by 160% in the first half of 2021, which stood at 2.6 million units. In addition, China remained the world’s top EV market, with 1.1 million vehicles sold in the first half of 2021, accounting for 12% of sales. Therefore, increasing usage of electric vehicles is driving the cathode materials market growth. Major players in the cathode materials market are 3M, BASF SE, Johnson Matthey plc, Kureha Corporation, LG Chem Ltd., Mitsubishi Chemical Corporation, Mitsui Mining & Smelting Co.Ltd., NEI Corporation, POSCO, Showa Denko Materials Co.Ltd., Toda Kogyo Corp, Gravita India Limited, AME Energy Co.Ltd., Nano One Materials Corp., Ube Industries, Asahi Kasei Corporation, Kureha, Advanced Lithium Electrochemistry Co. Ltd., Nippon Chemical Industrial Co.Ltd., and Tanaka Chemical Corporation. Technological innovations have emerged as the key trend gaining popularity in the cathode materials market. Major companies operating in the cathode materials sector are focused on introducing new technological innovations to sustain their position in the market. For instance, in April 2022, Ascend Elements, a US-based company that produces cathode active materials, launched Hydro-to-Cathode process technology. This technology helps to transform critical elements from recycled lithium-ion batteries into new cathode materials. This is an advanced technology for producing cathode materials by using recycled batteries. In January 2020, BASF Group, a Germany-based chemical company that manufactures cathode materials, acquired Solvay's polyamide for a deal amount of USD1.39 billion (€1.3 billion). This acquisition broadens BASF's polyamide capabilities with innovative and well-known products such as Technyl. Solvay is a Belgium-based company operating in cathode materials. North America was the largest region in the cathode materials market in 2022. Asia-Pacific is expected to be the fastest-growing regions in the forecast period. The regions covered in the cathode materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the cathode materials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The cathode materials market consists of sales of Ni-rich layered oxide, Lithium-excess cathode oxides, anionic redox chemistry of cathode materials, high-voltage cathode materials, cobalt-free cathode materials, polyanionic cathode materials, spinel-type cathode materials, organic cathode materials, and spinel-type cathode materials. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The cathode materials market research report is one of a series of new reports from The Business Research Company that provides cathode materials market statistics, including cathode materials industry global market size, regional shares, competitors with a cathode materials market share, detailed cathode materials market segments, market trends and opportunities, and any further data you may need to thrive in the cathode materials industry. This cathode materials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A cardiac pacemaker refers to a small electronic device that generates electrical impulses and prevents the heart from beating too fast or slow and helps in treating heart conditions such as arrhythmias is a heart condition where the heart beats irregularly. The cardiac pacemakers are used to maintain the rhythm of heartbeats. The main types of cardiac pacemakers include implantable and external implantable cardiac pacemakers is a device that generates electrical impulses to maintain the heart rate and are installed inside the chest through surgery. The different cardiac pacemaker technologies include biventricular, single-chambered, and dual-chambered. The cardiac pacemaker applications include arrhythmias, heart blockage, atrial fibrillation, long QT syndrome, congestive cardiac failure, and other applications used by end-users including clinics and hospitals, ambulatory surgical centers, and cardiac care centers. The global cardiac pacemakers market is segmented - 1) By Type: Implantable, External 2) By Technology: Biventricular, Single Chambered, Dual Chambered 3) By Application: Arrhythmias, Heart Blockage, Atrial Fibrillation, Long QT Syndrome, Congestive Cardiac Failure, Other Applications 4) By End User: Clinics And Hospitals, Ambulatory Surgical Centers, Cardiac Care Centers The global cardiac pacemakers market size grew from $4.28 billion in 2022 to $4.52 billion in 2023 at a compound annual growth rate (CAGR) of 5.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the cardiac pacemakers is expected to grow to $5.28 billion in 2027 at a CAGR of 4.0%. An increase in cardiovascular diseases is significantly contributing to the growth of the cardiac pacemaker market. Cardiovascular disease (CVD) refers to disorders that affect the heart or blood vessels. These include arrhythmias, aorta disease, congenital heart disease, heart attack, and others. Cardiac pacemakers are electric activity-generating devices that are used to treat patients suffering from cardiovascular diseases.According to the Center for Disease Control and prevention, an American national public health agency, approximately 697,000 people in the US died from heart disease in 2020 which converted to almost 1 in 5 deaths. Therefore, the rising incidence of cardiovascular diseases will drive the growth of the cardiac pacemaker market. Major players in the cardiac pacemakers market are Medtronic PLC, Lepu Medical Technology Co., Abbott Inc., Biotronik SE & Co. KG, Boston Scientific Corporation, LivaNova PLC, Medico SRL, Osypka AG, Oscor Inc., MicroPort Scientific Corporation, Pacetronix, Zoll Medical Corporation, Cook Medical, Vitatron, St Jude Medical Inc., and Cordis Corporation. New innovations are a key trend in the cardiac pacemaker market. Major players are making innovations like leadless cardiac pacemakers to cater to the cardiac pacemaker market in a better way. The leadless pacemaker is a self-contained generator and electrode system and is 90% smaller than a transvenous pacemaker implanted immediately into the right ventricle. There is no need for a chest incision or subcutaneous generator pocket because the device is placed via a femoral vein transcatheter technique is a minimally invasive technique to repair an inadequately opening narrowed aortic valve. For instance, in January 2022, Medtronic PLC., an Ireland-based medical devices company, introduced their leadless pacemaker Micra AV Transcatheter Pacing System (TPS). The Micra AV helps in patients' treatment with AV block when the electrical communication between the heart's ventricle and atria is compromised. In July 2022, Orchestra BioMed, a US-based company focused on developing transformative therapeutic products, collaborated with Medtronic. The collaboration between Medtronic and Orchestra BioMed is to develop BackBeat Cardiac Neuromodulation Therapy (CNT), a potential therapy for hypertension in people who need a cardiac pacemaker. Medtronic is an Ireland-based company that provides healthcare technology. North America was the largest region in the cardiac pacemakers market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac pacemakers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the cardiac pacemakers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The cardiac pacemaker market consists of sales of single chamber, dual chamber and Biventricular pacemakers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The cardiac pacemakers market research report is one of a series of new reports from The Business Research Company that provides cardiac pacemakers market statistics, including cardiac pacemakers industry global market size, regional shares, competitors with a cardiac pacemakers market share, detailed cardiac pacemakers market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac pacemakers industry. This cardiac pacemakers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.